Merck & Co, Inc.
Merck & Co., Inc., is committed to make pediatric Raltegravir available at no profit in low income, least developed countries and across Sub-saharan African countries until generics are available.
Committed by:
Merck & Co, Inc
Sub-Actions & Milestones
Sub-action Merck.1

Merck & Co., Inc., is committed to make pediatric Raltegravir available at no profit in low income, least developed countries and across Sub-saharan African countries until generics are available.

-

Merck & Co., Inc., confirmed (in a meeting with PEPFAR) their intention to provide paediatric drugs at access pricing until generics are available, and potentially beyond in LMIC.

-

Milestone Merck.1.1

-

-

-

-

Document (s)

-

-

-

-

Updates

Notes

Responsible